Medicine and Dentistry
Adenomyosis
40%
Adnexa
31%
Adnexal Mass
44%
Adverse Event
24%
Anaphylaxis
24%
Angioleiomyoma
38%
Artery Ligation
24%
Bisphenol A
36%
Breast Cancer
24%
Computer Assisted Tomography
90%
Continuous Positive Airway Pressure
24%
Controlled Ovarian Hyperstimulation
24%
Da Vinci Surgical System
62%
Diagnostic Performance
28%
Disease
30%
Early Menopause
26%
Electrical Impedance Tomography
24%
Endometriosis
42%
Endometrium
30%
Fertility Preservation
64%
Glucose Intolerance
24%
Gynecologic Disease
48%
Gynecological Surgery
29%
Hysterectomy
42%
Incision
52%
Insulin Resistance
62%
Middle Age
24%
Myoma
61%
Neck
24%
Neoplasm
30%
Numeric Rating Scale
24%
Operation Duration
38%
Pelvis
35%
Phthalic Acid
30%
Polycystic Ovary Syndrome
100%
Postoperative Pain
28%
Predictive Marker
24%
Premenopause
26%
Sacrocolpopexy
32%
Socioeconomic Status
24%
Surgery
36%
Tidal Volume
28%
Triacylglycerol
39%
Urine Incontinence
24%
Uterine Artery
24%
Uterine Artery Embolization
60%
Uterine Cancer
24%
Uterine Fibroid
84%
Uterine Myomectomy
79%
Uterus Bleeding
43%
Pharmacology, Toxicology and Pharmaceutical Science
4,4' Isopropylidenediphenol
36%
Actaea racemosa
36%
Adenomyosis
30%
Amenorrhea
8%
Androgen
6%
Bleeding
10%
C Reactive Protein
12%
Cimicifuga Racemosa Extract
6%
Cisplatin
24%
Comorbidity
24%
Dienogest
36%
Diethylstilbestrol
16%
Disease
21%
Disease Marker
24%
Early Menopause
36%
Endocrine Disruptor
14%
Endometriosis
61%
Endometrium Carcinoma
12%
Endometrium Tumor
12%
Fragility Fracture
12%
Glucose Intolerance
24%
Gynecologic Disease
25%
Hip Fracture
6%
Hot Flush
6%
Hyperandrogenism
12%
Hypericum perforatum
24%
ICD-10
7%
Impaired Glucose Tolerance
12%
Insulin Resistance
50%
Levonorgestrel
12%
Low Density Lipoprotein Cholesterol
9%
Menopausal Syndrome
24%
Metabolic Disorder
7%
Muellerian Inhibiting Factor
24%
Non Insulin Dependent Diabetes Mellitus
12%
Nonalcoholic Fatty Liver
12%
Ovary Insufficiency
14%
Ovary Polycystic Disease
62%
Phthalic Acid
30%
Placebo
14%
Premature Ovarian Failure
28%
Prevalence
19%
Progesterone
7%
Prospective Cohort Study
24%
Replacement Therapy
12%
Side Effect
8%
Spotting
12%
Triacylglycerol
43%
Uterus Bleeding
27%
Vitamin D
6%
Biochemistry, Genetics and Molecular Biology
Ataxia Telangiectasia Mutated
24%
Blood Level
7%
Blood Plasma
6%
Bone Mass
12%
Bone Remodeling
12%
BRCA1
24%
BRCA2
7%
C-Reactive Protein
18%
Chromogenic In Situ Hybridization
24%
Chromosomal Aberration
24%
Chromosome 3
7%
Chromosome 9
7%
Cisplatin
24%
Cross Sectional Study
7%
Endometrium
7%
FOXO3
24%
Gelatinase A
24%
Gene Polymorphism
24%
Gene Repair
7%
Genome-Wide Association Study
16%
Genotyping
9%
Germ Cell
7%
Germline
7%
Glucose Level
6%
Glucose Metabolism
24%
Glucose Test
8%
Glucose Tolerance Test
8%
Haplotype
19%
Homeostasis
7%
Impaired Glucose Tolerance
18%
In Vitro Maturation
7%
Insulin Resistance
24%
Insulin Sensitivity
7%
Intron
9%
Lipid Storage
18%
Luteinizing Hormone
10%
Maturation
5%
Metalloprotease Inhibitor
24%
MMP2
24%
Monosomy
12%
Mouse Model
5%
Ovarian Reserve
31%
Prevalence
12%
Reproduction
7%
Single Nucleotide Polymorphism
24%
Testosterone
7%
Triglyceride
42%
Vitamin D
12%
Wild Type Mouse
7%